Researcher
Marc Jacquemin
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From23 Nov 2000 → Today
Projects
1 - 5 of 5
- Rapid and easy-to-perform FO-SPR-based assays for VWF antigen and functionality and insights into the vaccine-induced adaptive immune response against SARS-CoV-2From1 Aug 2019 → 25 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Addition of ImageStream facilities to the FACS CoreFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Cellular Interactions and Heterogeneity in Ischemic Cardiovascular DiseaseFrom1 Nov 2010 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
- Development of an innovative platform for generation of tailor-made fully human therapeutic monoclonal antibodies against human targetsFrom1 Jan 2010 → 31 Dec 2013Funding: SBO (Strategic basic research)
- PharmAbs: K.U.Leuven Antibody Center.From1 Sep 2009 → TodayFunding: IOF - Industrial Research Fund, IOF - mandates
Publications
41 - 50 of 71
- Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype.(2013)
Authors: Kris Covens, Bert Verbinnen, Nick Geukens, Isabelle Meyts, Frans Schuit, Leentje Van Lommel, Marc Jacquemin, Xavier Bossuyt
Pages: 5176 - 5183 - Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype(2013)
Authors: Kris Covens, Bert Verbinnen, Nick Geukens, Isabelle Meyts, Frans Schuit, Marc Jacquemin, Xavier Bossuyt
Pages: 5176 - 83 - Anticoagulation With Fondaparinux for Hemodiafiltration in Patients With Heparin-Induced Thrombocytopenia: Dose-Finding Study and Safety Evaluation(2013)
Authors: Kathleen Claes, Marc Jacquemin, Pieter Evenepoel, Dirk Kuypers, Peter Verhamme, Björn Meijers
Pages: 482 - 487 - Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump(2013)
Authors: Steven Jacobs, Filip Rega, Kathelijne Peerlinck, Marc Jacquemin, Johan Vanhaecke, Johan Van Cleemput, Bart Meyns
Pages: 539 - 45 - Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory(2013)
Authors: Jaan Toelen, Kathelijne Peerlinck, Marc Jacquemin
Pages: E133 - E138 - Increased Synapse Formation Obtained by T Cell Epitopes Containing a CxxC Motif in Flanking Residues Convert CD4+T Cells into Cytolytic Effectors(2012)
Authors: Luc Vander Elst, Wim Janssens, Marc Jacquemin, Jean-Marie Saint-Remy
- Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII(2012)
Authors: Marc Jacquemin, Kathelijne Peerlinck, Thomas Vanassche, Marc Hoylaerts, Peter Verhamme
Pages: 1371 - 1378 - Partial versus complete FVIII inhibition in a mouse model of venous thrombosis(2012)
Authors: Jan Emmerechts, Thomas Vanassche, Alexandre Kauskot, Marc Jacquemin, Marc Hoylaerts, Peter Verhamme
Pages: 514 - 519 - A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel(2012)
Authors: Marleen Depré, Jan de Hoon, Marc Jacquemin
Pages: 249 - 258 - Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial(2011)
Authors: Peter Verhamme, Marc Jacquemin
Pages: 664 - 671